Switzerland · 
What does Pureos Bioventures invest in?
Pureos Bioventures invests most often at Series B and Series A (100% of the rounds on record), in sectors such as Biotech, Medicines and Proteomics.
Pureos Bioventures highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Series B and Series A: 100% of its rounds
- 03
Led 3 rounds
What they do
Pureos Bioventures invests venture capital in private innovative drug development companiesFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- BiotechMedicinesProteomics
- Based in
- Freienbach, Switzerland
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2026
3 rounds
- Oct
- Sept
- Jun
- 2024
2 rounds
- Dec
- Jun
- 2019
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
13 of 24 we have independently watched raise
AnacardioArarisbiotechAriceum-therapeuticsCitryllFrmHummingbirdbioscienceImchecktherapeuticsMemo-therapeuticsNovagotherapeuticsTavobioTridek-One Closes aUniqurealentis.c hAcrivonAraris Biotech RanksAraris Biotech ShortlistedEngimmuneInvesteuropeOmbudsmanPulsesightSwissbiotechToolsUnpribaselaunch.ch
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.